Allarity Therapeutics, Inc. Other Operating Income (Expense), Net
Allarity Therapeutics, Inc. (ALLR) reported Other Operating Income (Expense), Net of $2.66 million for the 3-month period ending 2021-09-30, per its 10-Q/A filed 2022-05-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherOperatingIncomeExpenseNet · last filed 2022-05-17
- Allarity Therapeutics, Inc. other operating income (expense), net for the quarter ending 2021-09-30 was $2.66M, a 816.55% increase year-over-year.
- Allarity Therapeutics, Inc. other operating income (expense), net for the quarter ending 2020-09-30 was $290.00K.
| Period end | Other Operating Income (Expense), Net 3 month | Other Operating Income (Expense), Net 9 month |
|---|---|---|
| 2021-09-30 | $2.66M 10-Q/A · filed 2022-05-17 | $1.08M 10-Q/A · filed 2022-05-17 |
| 2020-09-30 | $290.00K 10-Q/A · filed 2022-05-17 | $991.00K 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |